People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | — | Biotechnology | Series C | $121.5M | $2.1B | 2021 |
Tomas Evan Kiselak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tomas Evan Kiselak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leon O. Moulder, Jr. | 1 | 6 |
| Jonathan Violin | 1 | 5 |
| Leon Moulder | 1 | 3 |
| Leon Moulder, Jr. | 1 | 3 |
| Kenneth Evan Thompson | 1 | 1 |
| Paula Evan Soteropoulos | 1 | 1 |
| Jonathan Evan Violin | 1 | 1 |
| Lei Evan Meng | 1 | 1 |
| Marino Garcia | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.